Protheragen Debuts Microbiota Research Service for Obesity

Nov 20, 2026

United States, November 20, 2026 /MarketersMEDIA/ -- Protheragen, a specialized Contract Research Organization (CRO) dedicated to preclinical obesity research, today announced the launch of its Obesity Microbiota Research Service, an end-to-end research solution designed to examine the relationship between gut microbiota and obesity. The service encompasses animal model development, sample collection, 16S rRNA gene sequencing and/or shotgun metagenomic sequencing, and advanced bioinformatics and analytics. Leveraging research in obesity, microbiomics, and systems biology, the service focuses on identifying and prioritizing microbial targets that can aid in the development of next-generation anti-obesity therapeutics for biotechnology and pharmaceutical companies.

Research indicates that imbalances in gut microbial populations can influence the development of metabolic disorders and obesity, and ongoing work aims to elucidate the mechanisms by which these microbial populations contribute to obesity and to develop therapeutic strategies that modulate them. Protheragen's Obesity Research Platform provides biotechnology and pharmaceutical companies with an integrated system to perform preclinical research on obesity and related disorders, facilitate the identification of therapeutic targets, and support the development of personalized microbiome-modulating strategies.

The Obesity Microbiota Research Service standardizes and streamlines its processes to provide clients with reproducible data. Once an appropriate animal model (e.g., mice or rats) is selected, the service can induce obesity using various means, including dietary manipulations, environmental modifications, and genetic manipulations. After sample collection (e.g., blood, feces, and intestinal tissues), the service provides specialized processing to protect the microbial contents and increase the precision of analysis. The service uses various techniques—including 16S rRNA gene sequencing, metagenomics, and metabolomics—to characterize microbial components and their metabolites, and to elucidate their effects on host physiology. Various bioinformatics and statistical tools are used to analyze the data and draw conclusions regarding the functional capabilities of the microbial components and their roles in obesity. This service provides clients with the ability to understand functionally important microbial components and groups, identify dysbiotic microbiota associated with obesity, and support the development of microbiota-based therapies for obesity.

Beyond microbiota-focused studies, the Obesity Microbiota Research Service is part of the broader Obesity Research Platform, which supports the entire spectrum of anti-obesity therapeutic development—including small-molecule drugs that modulate the gut microbiota, gene and cell therapies, antibody therapies, tissue engineering, and other transformative approaches. Rigorous preclinical validation is conducted to provide scientific justification for advancing a therapeutic candidate to clinical trials. Each candidate undergoes pharmacodynamic and pharmacokinetic studies, toxicological evaluation, and safety assessment, with bioanalytical support provided throughout.

About Protheragen

Protheragen is a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in obesity. Driven by a passion for scientific innovation and a commitment to client success, the company has established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics. Its integrated Obesity Research Platform seamlessly combines expertise across metabolism, inflammation, and cardiovascular biology, enabling a holistic approach to obesity research and therapy development. The company maintains quality control standards throughout its preclinical services to support the integrity and regulatory acceptance of generated data. For more information about the Obesity Microbiota Research Service, please contact Protheragen.

Contact Info:
Name: Anna White
Email: Send Email
Organization: Protheragen
Website: https://www.obesityscientific.com/

Release ID: 89210336

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

MORE NEWS
Cauvery Water Row: Supreme Court Rejects Tamil Nadu’s Pleas For 11 TMC From Karnataka | News 18
Nov 20, 2026
Cauvery Water Row: Supreme Court Rejects Tamil Nadu’s Pleas For 11 TMC From Karnataka | News 18

The Supreme Court has dismissed Tamil Nadu's pleas seeking the release of around 11 TMC of Cauvery river water from Karnataka, in a fresh setback to the state's demand for its alleged outstanding share.A bench of Justices Vikram Nath and Aparesh Kumar Singh rejected two applications filed by the Tamil Nadu government. Tamil Nadu had claimed a shortfall of approximately 11.7 TMC in water flows at Billigundulu, the key measuring point on the Karnataka-Tamil Nadu border, and sought directions for Karnataka to make up the deficit.The state had argued that water shortages were affecting farmers and crops, and that Karnataka should release the outstanding water at the rate of around 1.3 TMC per day over 10 days. Karnataka opposed the demand, citing deficient rainfall, drought conditions in several districts and reduced water availability for irrigation.The court also made a sharp observation after noting that Tamil Nadu had filed another application in the matter.The Cauvery water-sharing dispute between Tamil Nadu and Karnataka has remained a contentious inter-state issue for decades. Under the Supreme Court's water-sharing framework, Karnataka is required to release 177 TMC to Tamil Nadu in a normal water year, with allocations adjusted during distress years.Watch this report for the latest developments in the Cauvery water dispute, the Supreme Court's order and what it means for farmers and the two states. n18oc_indiaCNN-News18 is your trusted source for breaking news, updates, and in-depth analysis from around the world. CNN-News18 is dedicated to bringing you the latest news, trends, and insights, helping you stay informed and up-to-date. Subscribe Now and join our community of informed and engaged viewers. Follow Every Breaking Story LIVE Watch News18 LIVE 24x7: https://youtube.com/live/rfDx1HMvXbQFollow us on Google: news18.co/cn18gFollow CNN News18 on X: https://x.com/CNNnews18Follow CNN News18 on Instagram: https://www.instagram.com/cnnnews18/Follow CNN News18 on Facebook: facebook.com/cnnnews18 with latest headlines on politics, sports and entertainment on news18.comNews18 Mobile App - https://onelink.to/desc-youtube

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Copyright © 2015 - 2026 Recent Discovery. All Rights Reserved.